Home / Cyclophosphamide / Canada
CA ATC L01AA01 · updated 2 Nov 2026
Cyclophosphamide shortage in Canada
Is there a Cyclophosphamide shortage in Canada?
Yes. As of 2 Nov 2026, 4 Cyclophosphamide products are reported short in Canada, the first since 13 Feb 2026. The company estimate for the return is 31 Dec 2026. Main reason: increased demand.
Also short in Germany, France, Italy, Spain, Austria, Belgium, Switzerland, Czechia, Sweden, Japan, Australia. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | PROCYTOX (500mg vials) | BAXTER CORPORATION | 13 Feb 2026 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | CYCLOPHOSPHAMIDE FOR INJECTION USP (1 VIAL) | STERIMAX INC | 20 Feb 2026 | not given | Increased demand Demand increase for the drug |
| CA | CYCLOPHOSPHAMIDE FOR INJECTION USP (1 VIAL) | STERIMAX INC | 20 Feb 2026 | not given | Increased demand Demand increase for the drug |
| CA | PROCYTOX (200mg / 20mL vial (Prod. Code 2638B5039)) discontinuation | BAXTER CORPORATION | not given | 31 Dec 2026 | Not stated |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.